Trials / Completed
CompletedNCT03802903
Efficacy and Safety of Remo-Wax for Removal of Impacted Earwax
Efficacy and Safety of Remo-Wax for Removal of Impacted Earwax; an Open, Single-arm, Non-randomised, Multicentre Clinical Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 52 (actual)
- Sponsor
- Orion Corporation, Orion Pharma · Industry
- Sex
- All
- Age
- 1 Year
- Healthy volunteers
- Not accepted
Summary
The study evaluates if Remo-Wax ear drops can soften impacted earwax.
Detailed description
This is an open, single-arm multicentre study to confirm the efficacy and safety of a commercially available Remo-Wax ear drops containing allantoin for dissolving and removing impacted earwax. Subjects that qualify for enrollment and provide informed consent wil be treated with topical earwax softening product.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Remo-Wax | topical treatment |
Timeline
- Start date
- 2019-03-12
- Primary completion
- 2019-04-29
- Completion
- 2019-04-29
- First posted
- 2019-01-14
- Last updated
- 2019-05-15
Locations
1 site across 1 country: Lithuania
Source: ClinicalTrials.gov record NCT03802903. Inclusion in this directory is not an endorsement.